000 | 00857 a2200265 4500 | ||
---|---|---|---|
005 | 20250514232725.0 | ||
264 | 0 | _c20050721 | |
008 | 200507s 0 0 eng d | ||
022 | _a1744-7658 | ||
024 | 7 |
_a10.1517/13543784.7.9.1439 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchlom, J | |
245 | 0 | 0 |
_aCancer vaccine development. _h[electronic resource] |
260 |
_bExpert opinion on investigational drugs _cSep 1998 |
||
300 |
_a1439-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aTsang, K Y | |
700 | 1 | _aKantor, J A | |
700 | 1 | _aAbrams, S I | |
700 | 1 | _aZaremba, S | |
700 | 1 | _aGreiner, J | |
700 | 1 | _aHodge, J W | |
773 | 0 |
_tExpert opinion on investigational drugs _gvol. 7 _gno. 9 _gp. 1439-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543784.7.9.1439 _zAvailable from publisher's website |
999 |
_c15649045 _d15649045 |